LeonaBio, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
LeonaBio, Inc. (LONA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.22M.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $396.00K.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$672.00K, a 259.62% decline year-over-year.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$603.00K.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.44M.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.51M, a 2320.35% decline from fiscal 2023.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $113.00K, a 91.01% decline from fiscal 2022.
- LeonaBio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.26M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.61M 10-Q · filed 2026-08-14 | $1.94M derived: sum of 3 quarters · filed 2026-08-14 | $1.34M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $396.00K 10-Q · filed 2026-05-07 | -$276.00K derived: sum of 2 quarters · filed 2026-05-07 | -$879.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.69M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.27M derived: sum of 2 quarters · filed 2026-03-31 | -$2.09M derived: sum of 3 quarters · filed 2026-08-14 | -$2.44M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.41M derived: sum of 2 quarters · filed 2026-08-14 | -$1.77M 10-Q · filed 2025-11-06 | -$1.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.16M 10-Q · filed 2026-08-14 | -$743.00K derived: sum of 3 quarters · filed 2026-08-14 | -$2.53M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$353.00K 10-Q · filed 2026-05-07 | $68.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.72M derived: sum of 3 quarters · filed 2026-05-07 | -$1.71M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.37M derived: sum of 2 quarters · filed 2026-03-31 | -$1.35M derived: sum of 3 quarters · filed 2026-03-31 | -$2.51M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.77M derived: sum of 2 quarters · filed 2025-11-06 | -$2.93M 10-Q · filed 2025-11-06 | -$3.18M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.14M 10-Q · filed 2025-08-07 | -$1.39M derived: sum of 3 quarters · filed 2025-08-07 | -$1.11M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.16M 10-Q · filed 2025-05-09 | -$1.41M derived: sum of 2 quarters · filed 2025-05-09 | -$1.13M derived: sum of 3 quarters · filed 2025-05-09 | -$2.01M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $26.00K derived: sum of 2 quarters · filed 2025-02-27 | -$857.00K derived: sum of 3 quarters · filed 2025-02-27 | $113.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$604.00K derived: sum of 2 quarters · filed 2024-11-07 | $366.00K 10-Q · filed 2024-11-07 | $18.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$883.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $87.00K 10-Q · filed 2024-08-01 | -$261.00K derived: sum of 3 quarters · filed 2024-08-01 | $2.49M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $970.00K 10-Q · filed 2024-05-15 | $622.00K derived: sum of 2 quarters · filed 2024-05-15 | $3.38M derived: sum of 3 quarters · filed 2024-05-15 | $3.37M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.41M derived: sum of 2 quarters · filed 2024-02-22 | $2.40M derived: sum of 3 quarters · filed 2024-02-22 | $1.26M 10-K · filed 2024-02-22 |
| 2022-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.75M derived: sum of 2 quarters · filed 2023-11-09 | $1.60M 10-Q · filed 2023-11-09 | $5.11M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.15M 10-Q · filed 2023-08-10 | $2.35M derived: sum of 3 quarters · filed 2023-08-10 | $418.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.14M 10-Q · filed 2023-05-11 | $2.36M derived: sum of 2 quarters · filed 2023-05-11 | $426.00K derived: sum of 3 quarters · filed 2023-05-11 | -$877.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.57M derived: sum of 2 quarters · filed 2023-03-23 | $264.00K derived: sum of 3 quarters · filed 2023-03-23 | -$1.65M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$3.24M derived: sum of 2 quarters · filed 2022-11-10 | -$5.15M 10-Q · filed 2022-11-10 | -$4.76M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.22M 10-Q · filed 2022-08-15 | -$2.83M derived: sum of 3 quarters · filed 2022-08-15 | $1.89M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$1.91M 10-Q · filed 2022-05-12 | -$1.52M derived: sum of 2 quarters · filed 2022-05-12 | $3.19M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $5.11M derived: sum of 2 quarters · filed 2022-03-28 | $6.31M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.92M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.20M 10-Q · filed 2021-08-16 | |||
| 2019-09-30 | -$16.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |